BMC Infectious Diseases (Sep 2023)

Immune responses of patients on maintenance hemodialysis after infection by SARS-CoV-2: a prospective observational cohort study

  • Dimitra Bacharaki,
  • Minas Karagiannis,
  • Panagiotis Giannakopoulos,
  • Evangelos Papachristou,
  • Dimitrios Divanis,
  • Aggeliki Sardeli,
  • Dimitra Petrou,
  • Petros Nikolopoulos,
  • Adamantia Bratsiakou,
  • Vassiliki Zoi,
  • Nikitas Piliouras,
  • Georgia Damoraki,
  • Vassilios Liakopoulos,
  • Dimitrios Goumenos,
  • Evangelos J. Giamarellos-Bourboulis

DOI
https://doi.org/10.1186/s12879-023-08569-2
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Immune dysregulation in patients with acute COVID-19 under chronic hemodialysis (CHD) is fully not elucidated. The changes of mononuclear counts and mediators before and after HD and associations with final outcome were studied. Method In this prospective study, hospitalized patients with moderate-to-severe COVID-19 under CHD and matched comparators under HD were analyzed for their absolute counts of lymphoid cells and circulating inflammatory mediators. Blood samples were collected before start and at the end of the first HD session; dialysate samples were also collected. Result Fifty-nine patients with acute COVID-19 under CHD and 20 uninfected comparators under CHD were enrolled. Circulating concentrations of tumor necrosis factor-alpha (TNFα), interleukin (IL)-10, interferon-γ and platelet-derived growth factor-A were increased in patients. Concentrations of mediators did not differ before and after HD. Significant decreases of CD4-lymphocytes and CD19-lymphocytes were found in patients. The decrease of the expression of HLA-DR on CD14-monocytes was associated with unfavorable outcome (defined as WHO-CPS 6 or more by day 28); increased counts of CD19-lymphocytes were associated with better outcomes. Conclusion Patients under CHD develop an inflammatory reaction to SARS-CoV-2 characterized by increase of inflammatory mediators, decrease of circulating T-lymphocytes and decrease of the expression of HLA-DR on CD14-monocytes.

Keywords